 | • レポートコード：QAF21511 • 出版社/出版日：QYResearch / 2021年5月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（即日納品） • 産業分類：化学＆材料 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のヘパリン市場について種類別（ヘパリンナトリウム、ヘパリンカルシウム、その他）、用途別（UFH、LMWH）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ヘパリン市場の概要 ・世界の主要地域別ヘパリン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のヘパリン市場規模2016-2021：種類別（ヘパリンナトリウム、ヘパリンカルシウム、その他） ・世界のヘパリン市場予測2012-2027：種類別（ヘパリンナトリウム、ヘパリンカルシウム、その他） ・世界のヘパリン市場規模2016-2021：用途別（UFH、LMWH） ・世界のヘパリン市場予測2012-2027：用途別（UFH、LMWH） ・ヘパリンのアメリカ市場規模と予測2016-2021 ・ヘパリンのヨーロッパ市場規模と予測2016-2021 ・ヘパリンの中国市場規模と予測2016-2021 ・ヘパリンの日本市場規模と予測2016-2021 ・ヘパリンの東南アジア市場規模と予測2016-2021 ・ヘパリンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Hepalink、Changshan Pharm、Qianhong Bio-pharma、Opocrin、Pfizer、Aspen Oss、King-friend Biochemical Pharmaceutical、Bioibérica、Dongcheng Biochemicals、Jiulong Biochemicals、Tiandong、Xinbai、Yino Pharma、Deebio） ・ヘパリンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヘパリンの市場動向・機会・課題 ・調査の結論 |
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine
Heparin API is an anticoagulant (blood thinner) that prevents the formation of blood clots. With the accelerated pace of life and increasing aging population, global morbidity and mortality of cardiovascular and cerebrovascular disease are increased year by year. Heparin API is an efficient solution to those diseases.
Raw materials of Heparin API are mainly porcine intestine, bovine lung and bovine intestine, etc. China pig slaughter amount accounted for more than 50% of the world. It has most abundant raw material resources all over the world.
The classification of Heparin includes Heparin Sodium, Heparin Calcium and others, and the proportion of Heparin Sodium in 2016 is about 88%, and the proportion is in decreasing trend from 2012 to 2016.
Heparin is widely used UFH and LMWH. The most proportion of Heparin is used in LMWH, and the proportion in 2016 is 88.9%
Europe is the largest consumption place, with a consumption market share nearly 40% in 2016. Following Europe, United Stated is the second largest consumption place with the consumption market share of 36%.
Market competition is not intense. Hepalink, Bioibérica, Changshan Pharm, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Heparin Market
The global Heparin market was valued at US$ 1132.9 in 2020 and will reach US$ 1384.5 million by the end of 2027, growing at a CAGR of 3.4% during 2022-2027.
Global Heparin Scope and Market Size
The global Heparin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Heparin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Heparin Sodium
Heparin Calcium
Other
Segment by Application
UFH
LMWH
The Heparin market is analysed and market size information is provided by regions (countries). Segment by Application, the Heparin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioibérica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma
Deebio
1 Heparin Market Overview
1.1 Heparin Product Scope
1.2 Heparin Segment by Type
1.2.1 Global Heparin Sales by Type (2016 & 2021 & 2027)
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.2.4 Other
1.3 Heparin Segment by Application
1.3.1 Global Heparin Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 UFH
1.3.3 LMWH
1.4 Heparin Market Estimates and Forecasts (2016-2027)
1.4.1 Global Heparin Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Heparin Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Heparin Price Trends (2016-2027)
2 Heparin Estimates and Forecasts by Region
2.1 Global Heparin Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Heparin Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Heparin Sales Market Share by Region (2016-2021)
2.2.2 Global Heparin Revenue Market Share by Region (2016-2021)
2.3 Global Heparin Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Heparin Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Heparin Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Heparin Estimates and Projections (2016-2027)
2.4.2 Europe Heparin Estimates and Projections (2016-2027)
2.4.3 China Heparin Estimates and Projections (2016-2027)
2.4.4 Japan Heparin Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Heparin Estimates and Projections (2016-2027)
2.4.6 India Heparin Estimates and Projections (2016-2027)
3 Global Heparin Competition Landscape by Players
3.1 Global Top Heparin Players by Sales (2016-2021)
3.2 Global Top Heparin Players by Revenue (2016-2021)
3.3 Global Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Heparin as of 2020)
3.4 Global Heparin Average Price by Company (2016-2021)
3.5 Manufacturers Heparin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Heparin Market Size by Type
4.1 Global Heparin Historic Market Review by Type (2016-2021)
4.1.1 Global Heparin Sales Market Share by Type (2016-2021)
4.1.2 Global Heparin Revenue Market Share by Type (2016-2021)
4.1.3 Global Heparin Price by Type (2016-2021)
4.2 Global Heparin Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Heparin Sales Forecast by Type (2022-2027)
4.2.2 Global Heparin Revenue Forecast by Type (2022-2027)
4.2.3 Global Heparin Price Forecast by Type (2022-2027)
5 Global Heparin Market Size by Application
5.1 Global Heparin Historic Market Review by Application (2016-2021)
5.1.1 Global Heparin Sales Market Share by Application (2016-2021)
5.1.2 Global Heparin Revenue Market Share by Application (2016-2021)
5.1.3 Global Heparin Price by Application (2016-2021)
5.2 Global Heparin Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Heparin Sales Forecast by Application (2022-2027)
5.2.2 Global Heparin Revenue Forecast by Application (2022-2027)
5.2.3 Global Heparin Price Forecast by Application (2022-2027)
6 North America Heparin Market Facts & Figures
6.1 North America Heparin Sales by Company
6.1.1 North America Heparin Sales by Company (2016-2021)
6.1.2 North America Heparin Revenue by Company (2016-2021)
6.2 North America Heparin Sales Breakdown by Type
6.2.1 North America Heparin Sales Breakdown by Type (2016-2021)
6.2.2 North America Heparin Sales Breakdown by Type (2022-2027)
6.3 North America Heparin Sales Breakdown by Application
6.3.1 North America Heparin Sales Breakdown by Application (2016-2021)
6.3.2 North America Heparin Sales Breakdown by Application (2022-2027)
7 Europe Heparin Market Facts & Figures
7.1 Europe Heparin Sales by Company
7.1.1 Europe Heparin Sales by Company (2016-2021)
7.1.2 Europe Heparin Revenue by Company (2016-2021)
7.2 Europe Heparin Sales Breakdown by Type
7.2.1 Europe Heparin Sales Breakdown by Type (2016-2021)
7.2.2 Europe Heparin Sales Breakdown by Type (2022-2027)
7.3 Europe Heparin Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)
8 China Heparin Market Facts & Figures
8.1 China Heparin Sales by Company
8.1.1 China Heparin Sales by Company (2016-2021)
8.1.2 China Heparin Revenue by Company (2016-2021)
8.2 China Heparin Sales Breakdown by Type
8.2.1 China Heparin Sales Breakdown by Type (2016-2021)
8.2.2 China Heparin Sales Breakdown by Type (2022-2027)
8.3 China Heparin Sales Breakdown by Application
8.3.1 China 316 Sales Breakdown by Application (2016-2021)
8.3.2 China 316 Sales Breakdown by Application (2022-2027)
9 Japan Heparin Market Facts & Figures
9.1 Japan Heparin Sales by Company
9.1.1 Japan Heparin Sales by Company (2016-2021)
9.1.2 Japan Heparin Revenue by Company (2016-2021)
9.2 Japan Heparin Sales Breakdown by Type
9.2.1 Japan Heparin Sales Breakdown by Type (2016-2021)
9.2.2 Japan Heparin Sales Breakdown by Type (2022-2027)
9.3 Japan Heparin Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Heparin Market Facts & Figures
10.1 Southeast Asia Heparin Sales by Company
10.1.1 Southeast Asia Heparin Sales by Company (2016-2021)
10.1.2 Southeast Asia Heparin Revenue by Company (2016-2021)
10.2 Southeast Asia Heparin Sales Breakdown by Type
10.2.1 Southeast Asia Heparin Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Heparin Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Heparin Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Heparin Market Facts & Figures
11.1 India Heparin Sales by Company
11.1.1 India Heparin Sales by Company (2016-2021)
11.1.2 India Heparin Revenue by Company (2016-2021)
11.2 India Heparin Sales Breakdown by Type
11.2.1 India Heparin Sales Breakdown by Type (2016-2021)
11.2.2 India Heparin Sales Breakdown by Type (2022-2027)
11.3 India Heparin Sales Breakdown by Application
11.3.1 India Heparin Sales Breakdown by Application (2016-2021)
11.3.2 India Heparin Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Heparin Business
12.1 Hepalink
12.1.1 Hepalink Corporation Information
12.1.2 Hepalink Business Overview
12.1.3 Hepalink Heparin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Hepalink Heparin Products Offered
12.1.5 Hepalink Recent Development
12.2 Changshan Pharm
12.2.1 Changshan Pharm Corporation Information
12.2.2 Changshan Pharm Business Overview
12.2.3 Changshan Pharm Heparin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Changshan Pharm Heparin Products Offered
12.2.5 Changshan Pharm Recent Development
12.3 Qianhong Bio-pharma
12.3.1 Qianhong Bio-pharma Corporation Information
12.3.2 Qianhong Bio-pharma Business Overview
12.3.3 Qianhong Bio-pharma Heparin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Qianhong Bio-pharma Heparin Products Offered
12.3.5 Qianhong Bio-pharma Recent Development
12.4 Opocrin
12.4.1 Opocrin Corporation Information
12.4.2 Opocrin Business Overview
12.4.3 Opocrin Heparin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Opocrin Heparin Products Offered
12.4.5 Opocrin Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Heparin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Heparin Products Offered
12.5.5 Pfizer Recent Development
12.6 Aspen Oss
12.6.1 Aspen Oss Corporation Information
12.6.2 Aspen Oss Business Overview
12.6.3 Aspen Oss Heparin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Aspen Oss Heparin Products Offered
12.6.5 Aspen Oss Recent Development
12.7 King-friend Biochemical Pharmaceutical
12.7.1 King-friend Biochemical Pharmaceutical Corporation Information
12.7.2 King-friend Biochemical Pharmaceutical Business Overview
12.7.3 King-friend Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 King-friend Biochemical Pharmaceutical Heparin Products Offered
12.7.5 King-friend Biochemical Pharmaceutical Recent Development
12.8 Bioibérica
12.8.1 Bioibérica Corporation Information
12.8.2 Bioibérica Business Overview
12.8.3 Bioibérica Heparin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bioibérica Heparin Products Offered
12.8.5 Bioibérica Recent Development
12.9 Dongcheng Biochemicals
12.9.1 Dongcheng Biochemicals Corporation Information
12.9.2 Dongcheng Biochemicals Business Overview
12.9.3 Dongcheng Biochemicals Heparin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Dongcheng Biochemicals Heparin Products Offered
12.9.5 Dongcheng Biochemicals Recent Development
12.10 Jiulong Biochemicals
12.10.1 Jiulong Biochemicals Corporation Information
12.10.2 Jiulong Biochemicals Business Overview
12.10.3 Jiulong Biochemicals Heparin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Jiulong Biochemicals Heparin Products Offered
12.10.5 Jiulong Biochemicals Recent Development
12.11 Tiandong
12.11.1 Tiandong Corporation Information
12.11.2 Tiandong Business Overview
12.11.3 Tiandong Heparin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Tiandong Heparin Products Offered
12.11.5 Tiandong Recent Development
12.12 Xinbai
12.12.1 Xinbai Corporation Information
12.12.2 Xinbai Business Overview
12.12.3 Xinbai Heparin Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Xinbai Heparin Products Offered
12.12.5 Xinbai Recent Development
12.13 Yino Pharma
12.13.1 Yino Pharma Corporation Information
12.13.2 Yino Pharma Business Overview
12.13.3 Yino Pharma Heparin Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Yino Pharma Heparin Products Offered
12.13.5 Yino Pharma Recent Development
12.14 Deebio
12.14.1 Deebio Corporation Information
12.14.2 Deebio Business Overview
12.14.3 Deebio Heparin Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Deebio Heparin Products Offered
12.14.5 Deebio Recent Development
13 Heparin Manufacturing Cost Analysis
13.1 Heparin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Heparin
13.4 Heparin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Heparin Distributors List
14.3 Heparin Customers
15 Market Dynamics
15.1 Heparin Market Trends
15.2 Heparin Drivers
15.3 Heparin Market Challenges
15.4 Heparin Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Heparin Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Heparin Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Heparin Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Heparin Sales (K MT) by Region (2016-2021)
Table 5. Global Heparin Sales Market Share by Region (2016-2021)
Table 6. Global Heparin Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Heparin Revenue Share by Region (2016-2021)
Table 8. Global Heparin Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Heparin Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Heparin Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Heparin Revenue Share Forecast by Region (2022-2027)
Table 12. Global Heparin Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Heparin Sales Share by Company (2016-2021)
Table 14. Global Heparin Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Heparin Revenue Share by Company (2016-2021)
Table 16. Global Heparin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heparin as of 2020)
Table 17. Global Heparin Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Heparin Manufacturing Sites and Area Served
Table 19. Manufacturers Heparin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Heparin Sales (K MT) by Type (2016-2021)
Table 22. Global Heparin Sales Share by Type (2016-2021)
Table 23. Global Heparin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Heparin Price (USD/MT) by Type (2016-2021)
Table 25. Global Heparin Sales Share by Type (2022-2027)
Table 26. Global Heparin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Heparin Revenue Share by Type (2022-2027)
Table 28. Global Heparin Price (USD/MT) by Type (2022-2027)
Table 29. Global Heparin Sales (K MT) by Application (2016-2021)
Table 30. Global Heparin Sales Share by Application (2016-2021)
Table 31. Global Heparin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Heparin Price (USD/MT) by Application (2016-2021)
Table 33. Global Heparin Sales (K MT) by Application (2022-2027)
Table 34. Global Heparin Sales Share by Application (2022-2027)
Table 35. Global Heparin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Heparin Revenue Share by Application (2022-2027)
Table 37. Global Heparin Price (USD/MT) by Application (2022-2027)
Table 38. North America Heparin Sales (K MT) by Company (2016-2021)
Table 39. North America Heparin Sales Market Share by Company (2016-2021)
Table 40. North America Heparin Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Heparin Revenue Market Share by Company (2016-2021)
Table 42. North America Heparin Sales by Type (2016-2021) & (K MT)
Table 43. North America Heparin Sales Market Share by Type (2016-2021)
Table 44. North America Heparin Sales by Type (2022-2027) & (K MT)
Table 45. North America Heparin Sales Market Share by Type (2022-2027)
Table 46. North America Heparin Sales by Application (2016-2021) & (K MT)
Table 47. North America Heparin Sales Market Share by Application (2016-2021)
Table 48. North America Heparin Sales by Application (2022-2027) & (K MT)
Table 49. North America Heparin Sales Market Share by Application (2022-2027)
Table 50. Europe Heparin Sales (K MT) by Company (2016-2021)
Table 51. Europe Heparin Sales Market Share by Company (2016-2021)
Table 52. Europe Heparin Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Heparin Revenue Market Share by Company (2016-2021)
Table 54. Europe Heparin Sales by Type (2016-2021) & (K MT)
Table 55. Europe Heparin Sales Market Share by Type (2016-2021)
Table 56. Europe Heparin Sales by Type (2022-2027) & (K MT)
Table 57. Europe Heparin Sales Market Share by Type (2022-2027)
Table 58. Europe Heparin Sales by Application (2016-2021) & (K MT)
Table 59. Europe Heparin Sales Market Share by Application (2016-2021)
Table 60. Europe Heparin Sales by Application (2022-2027) & (K MT)
Table 61. Europe Heparin Sales Market Share by Application (2022-2027)
Table 62. China Heparin Sales (K MT) by Company (2016-2021)
Table 63. China Heparin Sales Market Share by Company (2016-2021)
Table 64. China Heparin Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Heparin Revenue Market Share by Company (2016-2021)
Table 66. China Heparin Sales by Type (2016-2021) & (K MT)
Table 67. China Heparin Sales Market Share by Type (2016-2021)
Table 68. China Heparin Sales by Type (2022-2027) & (K MT)
Table 69. China Heparin Sales Market Share by Type (2022-2027)
Table 70. China Heparin Sales by Application (2016-2021) & (K MT)
Table 71. China Heparin Sales Market Share by Application (2016-2021)
Table 72. China Heparin Sales by Application (2022-2027) & (K MT)
Table 73. China Heparin Sales Market Share by Application (2022-2027)
Table 74. Japan Heparin Sales (K MT) by Company (2016-2021)
Table 75. Japan Heparin Sales Market Share by Company (2016-2021)
Table 76. Japan Heparin Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Heparin Revenue Market Share by Company (2016-2021)
Table 78. Japan Heparin Sales by Type (2016-2021) & (K MT)
Table 79. Japan Heparin Sales Market Share by Type (2016-2021)
Table 80. Japan Heparin Sales by Type (2022-2027) & (K MT)
Table 81. Japan Heparin Sales Market Share by Type (2022-2027)
Table 82. Japan Heparin Sales by Application (2016-2021) & (K MT)
Table 83. Japan Heparin Sales Market Share by Application (2016-2021)
Table 84. Japan Heparin Sales by Application (2022-2027) & (K MT)
Table 85. Japan Heparin Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Heparin Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Heparin Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Heparin Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Heparin Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Heparin Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Heparin Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Heparin Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Heparin Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Heparin Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Heparin Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Heparin Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Heparin Sales Market Share by Application (2022-2027)
Table 98. India Heparin Sales (K MT) by Company (2016-2021)
Table 99. India Heparin Sales Market Share by Company (2016-2021)
Table 100. India Heparin Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Heparin Revenue Market Share by Company (2016-2021)
Table 102. India Heparin Sales by Type (2016-2021) & (K MT)
Table 103. India Heparin Sales Market Share by Type (2016-2021)
Table 104. India Heparin Sales by Type (2022-2027) & (K MT)
Table 105. India Heparin Sales Market Share by Type (2022-2027)
Table 106. India Heparin Sales by Application (2016-2021) & (K MT)
Table 107. India Heparin Sales Market Share by Application (2016-2021)
Table 108. India Heparin Sales by Application (2022-2027) & (K MT)
Table 109. India Heparin Sales Market Share by Application (2022-2027)
Table 110. Hepalink Corporation Information
Table 111. Hepalink Description and Business Overview
Table 112. Hepalink Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Hepalink Heparin Product
Table 114. Hepalink Recent Development
Table 115. Changshan Pharm Corporation Information
Table 116. Changshan Pharm Description and Business Overview
Table 117. Changshan Pharm Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Changshan Pharm Heparin Product
Table 119. Changshan Pharm Recent Development
Table 120. Qianhong Bio-pharma Corporation Information
Table 121. Qianhong Bio-pharma Description and Business Overview
Table 122. Qianhong Bio-pharma Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Qianhong Bio-pharma Heparin Product
Table 124. Qianhong Bio-pharma Recent Development
Table 125. Opocrin Corporation Information
Table 126. Opocrin Description and Business Overview
Table 127. Opocrin Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Opocrin Heparin Product
Table 129. Opocrin Recent Development
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Pfizer Heparin Product
Table 134. Pfizer Recent Development
Table 135. Aspen Oss Corporation Information
Table 136. Aspen Oss Description and Business Overview
Table 137. Aspen Oss Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Aspen Oss Heparin Product
Table 139. Aspen Oss Recent Development
Table 140. King-friend Biochemical Pharmaceutical Corporation Information
Table 141. King-friend Biochemical Pharmaceutical Description and Business Overview
Table 142. King-friend Biochemical Pharmaceutical Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. King-friend Biochemical Pharmaceutical Heparin Product
Table 144. King-friend Biochemical Pharmaceutical Recent Development
Table 145. Bioibérica Corporation Information
Table 146. Bioibérica Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Bioibérica Description and Business Overview
Table 148. Bioibérica Heparin Product
Table 149. Bioibérica Recent Development
Table 150. Dongcheng Biochemicals Corporation Information
Table 151. Dongcheng Biochemicals Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Dongcheng Biochemicals Description and Business Overview
Table 153. Dongcheng Biochemicals Heparin Product
Table 154. Dongcheng Biochemicals Recent Development
Table 155. Jiulong Biochemicals Corporation Information
Table 156. Jiulong Biochemicals Description and Business Overview
Table 157. Jiulong Biochemicals Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Jiulong Biochemicals Heparin Product
Table 159. Jiulong Biochemicals Recent Development
Table 160. Tiandong Corporation Information
Table 161. Tiandong Description and Business Overview
Table 162. Tiandong Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Tiandong Heparin Product
Table 164. Tiandong Recent Development
Table 165. Xinbai Corporation Information
Table 166. Xinbai Description and Business Overview
Table 167. Xinbai Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Xinbai Heparin Product
Table 169. Xinbai Recent Development
Table 170. Yino Pharma Corporation Information
Table 171. Yino Pharma Description and Business Overview
Table 172. Yino Pharma Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Yino Pharma Heparin Product
Table 174. Yino Pharma Recent Development
Table 175. Deebio Corporation Information
Table 176. Deebio Description and Business Overview
Table 177. Deebio Heparin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Deebio Heparin Product
Table 179. Deebio Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Heparin Distributors List
Table 183. Heparin Customers List
Table 184. Heparin Market Trends
Table 185. Heparin Market Drivers
Table 186. Heparin Market Challenges
Table 187. Heparin Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Heparin Product Picture
Figure 2. Global Heparin Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Heparin Sales Market Share by Application in 2021 & 2027
Figure 6. UFH Examples
Figure 7. LMWH Examples
Figure 8. Global Heparin Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Heparin Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Heparin Sales (K MT) Growth Rate (2016-2027)
Figure 11. Global Heparin Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 12. Global Heparin Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Heparin Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Heparin Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Heparin Sales (K MT) Growth Rate (2016-2027)
Figure 16. Europe Heparin Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Heparin Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Heparin Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Heparin Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Heparin Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Heparin Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Heparin Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Heparin Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Heparin Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Heparin Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Heparin Players Market Share by Revenue in Heparin: 2016 & 2020
Figure 27. Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Heparin Revenue Share by Type (2016-2021)
Figure 29. Global Heparin Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Heparin Revenue Share by Application (2016-2021)
Figure 31. Global Heparin Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Heparin Sales Market Share by Type in 2020
Figure 33. North America Heparin Sales Market Share by Application in 2020
Figure 34. Europe Heparin Sales Market Share by Type in 2020
Figure 35. Europe Heparin Sales Market Share by Application in 2020
Figure 36. China Heparin Sales Market Share by Type in 2020
Figure 37. China Heparin Sales Market Share by Application in 2020
Figure 38. Japan Heparin Sales Market Share by Type in 2020
Figure 39. Japan Heparin Sales Market Share by Application in 2020
Figure 40. Southeast Asia Heparin Sales Market Share by Type in 2020
Figure 41. Southeast Asia Heparin Sales Market Share by Application in 2020
Figure 42. India Heparin Sales Market Share by Type in 2020
Figure 43. India Heparin Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Heparin
Figure 46. Manufacturing Process Analysis of Heparin
Figure 47. Heparin Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed